Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

Minniti, G; De Sanctis, V; Muni, R; Filippone, F; Bozzao, A; Valeriani, M; Osti, M F; De Paula, U; Lanzetta, G; Tombolini, V; Maurizi Enrici, R

Minniti, G; De Sanctis, V; Muni, R; Filippone, F; Bozzao, A; Valeriani, M; Osti, M F; De Paula, U; Lanzetta, G; Tombolini, V; Maurizi Enrici, R.

Affiliation

Minniti G; Department of Radiotherapy Oncology, S Andrea Hospital, University La Sapienza, Via di Grottarossa 1035, Rome, Italy. Giuseppe.Minniti@ospedalesantandrea.it

J Neurooncol ; 88(1): 97-103, 2008 May.

Article in En | MEDLINE | ID: mdl-18250965

Subject(s)

Aged/physiology; Antineoplastic Agents, Alkylating/therapeutic use; Brain Neoplasms/therapy; Dacarbazine/analogs & derivatives; Glioblastoma/therapy; Antineoplastic Agents, Alkylating/adverse effects; Brain Neoplasms/drug therapy; Brain Neoplasms/radiotherapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine/adverse effects; Dacarbazine/therapeutic use; Female; Glioblastoma/drug therapy; Glioblastoma/radiotherapy; Humans; Karnofsky Performance Status; Male; Neurosurgical Procedures; Survival; Temozolomide

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Aged / Glioblastoma / Antineoplastic Agents, Alkylating / Dacarbazine Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: J Neurooncol Year: 2008 Document type: Article

Fulltext

XML

PubMed Links

Search on Google